Magnus Doverskog

Chief Executive Officer

MSc in Organic Chemistry, PhD in Biotechnology from the Royal Institute of Technology (KTH) in Stockholm, and MBA from the Stockholm University School of Business, has broad knowledge from discovery and development projects of both small molecules and biologics. Previous positions at Astra Pain Control and Biovitrum AB, and most recently as CEO of IMED AB.

Otto Skolling

Business Development

Otto Skolling (Adj.) has a M.Sc. in Chemistry, VP Business Development at Karolinska Development AB, has 20 years of broad-based pharmaceutical and med tech. industry experience, including product development, business development and project management gained through management positions at Novozymes, Siemens Life Support Systems and Pharmacia & Upjohn.

Torbjörn Bäckström

Chief Science Officer

MD, PhD, co-founder and CEO of Umecrine AB, is currently professor at the Department of Clinical Science, Obstetrics and Gynecology, Umeå University. He is also head of the Umeå Neurosteroid Research Center. Professor Bäckström's main focus of research since 1972 is the effect of sex and stress hormones on the brain and conditions induced by these hormones, he has more than 400 scientific publications within this area and he is a frequently invited key-note speaker at scientific meetings around the world.